Related Experiment Video
Updated: Dec 12, 2025

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
Published on: May 25, 2022
[Ocular manifestations of coronavirus infection COVID-19 (clinical observation)]
D Yu Maychuk1, S N Atlas2, A O Loshkareva1
1S.N. Fyodorov National Medical Research Center «Eye Microsurgery», Moscow, Russia.
Abstract:
This paper describes possible clinical ocular manifestations of novel coronavirus infection COVID-19. Two clinical cases of conjunctivitis are examined. Due to the lack of ophthalmological approaches to the treatment of such patients, different management tactics are given based on the severity of local and systemic disease manifestations. Our research and practical management of these conditions showed the toxic and allergic nature of ocular surface manifestations in patients with COVID-19. Such cases are proposed to be treated similar to the conjunctivitis of "unclear origin" with components from antiviral and anti-allergic therapies.
Insights
This study examines ocular manifestations of coronavirus disease (COVID-19), focusing on conjunctivitis. Researchers suggest a toxic and allergic nature, recommending antiviral and anti-allergic treatments for affected patients.
Area of Science:
- Ophthalmology
- Infectious Diseases
- Virology
Background:
- Novel coronavirus infection, COVID-19, has emerged globally, necessitating understanding of its diverse clinical presentations.
- Ocular manifestations, such as conjunctivitis, can occur in patients with COVID-19, requiring specific management strategies.
- Limited established ophthalmological guidelines exist for treating COVID-19-related ocular conditions.
Observation:
- Two clinical cases of conjunctivitis in COVID-19 patients were analyzed.
- Ocular surface manifestations were observed to have characteristics of both toxic and allergic responses.
- Disease severity, both local and systemic, influenced the management approach.
Findings:
- COVID-19-associated conjunctivitis appears to be primarily toxic and allergic in nature.
- Effective management requires tailoring treatment based on the severity of ocular and systemic symptoms.
- The study identified potential therapeutic strategies for managing these specific ocular conditions.
Implications:
- Ophthalmologists should consider COVID-19 in the differential diagnosis of conjunctivitis, especially during outbreaks.
- Treatment protocols may benefit from incorporating antiviral and anti-allergic components, similar to idiopathic conjunctivitis.
- Further research is warranted to elucidate the precise mechanisms and optimize treatment for COVID-19 ocular sequelae.
Related Concept Videos
Glaucoma: Overview
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Accessory Structures of the Eye
Coronary Artery Disease III: Clinical Manifestations

